A drug called Rapamycin is injected into humans to help lessen the rejection of a new organ. However, U.S. scientists found that it significantly extends the lifespan of invertebrates, and now mammals (mice). They are excited because further research may produce a way to delay the onset of cancer and other aging disease and, thus, produce longer lives in humans.
A new research tool designed to increase the accuracy for determining the link between a person’s occupation and their risks of getting cancer, has been showcased to an international health research conference in the United States by a Queensland company which developed the software.
The U.S. Food and Drug Administration approved a skin-tumor cancer drug, Palladia, especially for dogs. Its use will greatly improve the health and well-being of our four-legged friends. Currently treated with human-related cancer drugs, this drug will more effectively treat skin tumor cancer within dogs.